MAP
NEO icon

Moody Aldrich Partners’s NeoGenomics NEO Stock Holding History

Moody Aldrich Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-63,697
Closed -$2.17M – 164
2021
Q4 		$2.17M Sell
63,697
-11,781
-16% -$461K 0.3% 87
2021
Q3 		$3.64M Sell
75,478
-15,769
-17% -$730K 0.46% 79
2021
Q2 		$4.12M Sell
91,247
-1,161
-1% -$51.4K 0.58% 76
2021
Q1 		$4.46M Buy
92,408
+1,437
+2% +$74.8K 0.64% 68
2020
Q4 		$4.9M Buy
90,971
+104
+0.1% +$4.7K 0.79% 61
2020
Q3 		$3.35M Buy
+90,867
New +$3.38M 0.7% 67
2018
Q4 		– Sell
-155,974
Closed -$2.39M – 106
2018
Q3 		$2.39M Buy
+155,974
New +$2.16M 0.69% 71

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Moody Aldrich Partners's NEO Position: Q1 2022 in Review

Moody Aldrich Partners sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 63,697 shares — an estimated $2.17M sold.

Moody Aldrich Partners first reported a position in NEO in Q3 2018 and held it in 7 quarters. The position peaked at $4.9M in Q4 2020. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Moody Aldrich Partners reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Moody Aldrich Partners sold 63,697 NeoGenomics shares in Q1 2022, an estimated $2.17M.
  • Moody Aldrich Partners first reported a position in NeoGenomics in Q3 2018 and held it in 7 quarters.
  • Moody Aldrich Partners's NeoGenomics position peaked at $4.9M in Q4 2020.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Moody Aldrich Partners's 13F filing for Q1 2022, filed 10 May 2022.